Investors & media
Financial data
Find the latest press releases, financial information, and performance updates.
Transforming rare disease care
We are a global specialty biopharmaceutical company expanding possibilities for people with rare diseases. With 50 years of experience in applying our scientific expertise and unique technologies to research, we continue to develop next-generation treatments and expand our global footprint to transform the lives of patients worldwide.
Newsroom
2025.11.21
JCR Pharmaceuticals celebrating 50 years
2025.11.26
JCR organizes and conducts API plant tour for local residents
2025.11.04
FY2025 second quarter results briefing session material
2025.11.04
FY2025 second quarter results briefing session – movie
2025.10.30
FY2025 Second quarter results briefing session material
Performance data
JCR Pharmaceuticals (4552.T)
Tokyo Currency in JPY
717.00
+11.00
(+1.56%)
Last updated 12/05/2025 at TSE market close
Quarterly results
Driven by science and compassion, we tackle some of the most complex challenges in rare disease. Every solution we develop is grounded in insight into the genetic and biological foundations of the conditions we aim to treat.
Contact us
Investors & media